Related Experiment Video
Updated: Nov 10, 2025
Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Age-Specific Dose Regimens of Dexmedetomidine for Pediatric Patients in Intensive Care Following Elective Surgery: A
Mamoru Takeuchi1, Shintaro Nemoto2, Yasuyuki Suzuki3
1Department of Anesthesiology and Critical Care Medicine, Jichi Medical University, Shimotsuke, Japan.
Insights
Dexmedetomidine effectively sedated pediatric ICU patients requiring mechanical ventilation, with 77% avoiding rescue sedatives. The drug demonstrated a favorable safety profile with mild adverse events in this surgical population.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Anesthesiology
Background:
- Sedation is crucial for pediatric patients undergoing mechanical ventilation in the ICU.
- Dexmedetomidine is a sedative-hypnotic agent with potential applications in pediatric intensive care.
Purpose of the Study:
- To evaluate the efficacy, safety, and pharmacokinetics of dexmedetomidine for sedation in pediatric surgery patients in the ICU.
- To determine if dexmedetomidine can provide adequate sedation without the need for rescue sedatives.
Main Methods:
- A Phase 3, multicenter, open-label study was conducted in 61 pediatric patients in Japan.
- Dexmedetomidine was administered intravenously without a loading dose at age-specific regimens.
- The primary endpoint assessed the need for rescue midazolam infusion.
Main Results:
- 77.0% of patients (47/61) did not require rescue midazolam.
- Adverse events occurred in 86.9% of patients, most commonly hypotension, bradycardia, and respiratory depression, which were generally mild.
- Serious adverse events were rare and not directly attributed to dexmedetomidine.
Conclusions:
- Age-specific dexmedetomidine regimens without a loading dose provide adequate sedation in pediatric ICU patients.
- The sedative regimen demonstrated a favorable safety profile with minimal hemodynamic and respiratory impact.
- Achieved plasma concentrations of dexmedetomidine were within the therapeutic range.
Objectives:
To demonstrate the efficacy, safety, and pharmacokinetics of dexmedetomidine as a potential sedative for pediatric surgery patients in the ICU.
Design:
Phase 3, multicenter, open-label study.
Setting:
This study included 61 patients at 13 tertiary hospitals in Japan.
Patients:
Pediatric patients (≥ 45 wk corrected gestational age to < 17 yr) undergoing intensive care treatment with mechanical ventilation requiring greater than 6 hours estimated duration of sedation following elective cardiac surgery.
Interventions:
Dexmedetomidine was IV administered without a loading dose at age-specific dose regimens 0.2-1.4 (< 6 yr) and 0.2-1.0 µg/kg/hr (≥ 6 yr). The primary endpoint was the percentage of patients who did not require a rescue sedative (midazolam) infusion during mechanical ventilation or for the first 24 hours of a greater than 24 hours ventilation following the commencement of dexmedetomidine administration.
Measurements And Main Results:
Overall, 47 of the 61 patients (77.0%) did not require rescue midazolam. Adverse events were reported in 53 patients (86.9%). Frequently observed adverse events were hypotension (47.5%), bradycardia (31.1%), and respiratory depression (26.2%). Most of these adverse events were mild, a few moderate, and none severe. Although serious adverse events occurred in four patients, including one cardiac tamponade resulting in the withdrawal of dexmedetomidine, none of the adverse events resulted in mortality or were directly related to dexmedetomidine. The plasma dexmedetomidine concentration generally reached the target concentration of 0.3-1.25 ng/mL at 1-2 hours prior to completion of administration or immediately prior to the commencement of tapering.
Conclusions:
The age-specific dose regimens of dexmedetomidine without an initial loading dose achieved an adequate sedation level during mechanical ventilation and caused no clinically significant adverse events in the intensive care pediatric patients. These effects were achieved within the therapeutic range of dexmedetomidine plasma concentration and were accompanied by minimal effects on hemodynamics and respiration.
Related Concept Videos
01:29Drug Dosing: Infants and Children
01:24Parenteral Anesthetics: Overview
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:15Drug Dosing: Geriatric Patients
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution